Literature DB >> 11127261

ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

D Gaffney1, G S Fell, D S O'Reilly.   

Abstract

Wilson's disease, the most common inherited disorder of copper metabolism, is a recessive genetic condition. The clinical presentation of Wilson's disease is very variable. It is characterised by low serum copper and caeruloplasmin concentrations coupled with the pathological accumulation of copper in the tissues. However, there are diagnostic difficulties and these are discussed. The current value of DNA diagnosis, both in gene tracking in families or as applied to de novo cases, is examined. Wilson's disease can be treated successfully but treatment must be life long. Patients are best treated by specialist centres with experience and expertise in the condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127261      PMCID: PMC1731102          DOI: 10.1136/jcp.53.11.807

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Wilson's disease presenting as acute fulminant hepatic failure.

Authors:  J G O'Donnell; I D Watson; G S Fell; M E Allison; R I Russell; P R Mills
Journal:  Scott Med J       Date:  1990-08       Impact factor: 0.729

2.  DNA-based presymptomatic diagnosis of Wilson disease.

Authors:  D Gaffney; J L Walker; J G O'Donnell; G S Fell; K F O'Neill; R H Park; R I Russell
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.

Authors:  C Martins da Costa; D Baldwin; B Portmann; Y Lolin; A P Mowat; G Mieli-Vergani
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

4.  Haplotype studies in Wilson disease.

Authors:  G R Thomas; P C Bull; E A Roberts; J M Walshe; D W Cox
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

5.  Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease.

Authors:  J B Tu; R Q Blackwell
Journal:  Metabolism       Date:  1967-06       Impact factor: 8.694

6.  The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.

Authors:  P C Bull; G R Thomas; J M Rommens; J R Forbes; D W Cox
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

7.  Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus.

Authors:  M Frydman; B Bonné-Tamir; L A Farrer; P M Conneally; A Magazanik; S Ashbel; Z Goldwitch
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  The discovery of the therapeutic use of D-penicillamine.

Authors:  J M Walshe
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb

9.  The management of pregnancy in Wilson's disease treated with trientine.

Authors:  J M Walshe
Journal:  Q J Med       Date:  1986-01

10.  Dangers of non-compliance in Wilson's disease.

Authors:  J M Walshe; A K Dixon
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

View more
  8 in total

1.  Electronic publishing and internet learning.

Authors:  P J van Diest; H Holzel; M Reid; M Crook; G Spickett
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.

Authors:  P J Twomey; A Viljoen; I M House; T M Reynolds; A S Wierzbicki
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

3.  P wave dispersion is prolonged in patients with Wilson's disease.

Authors:  Nurcan Arat; Sabite Kacar; Zehra Golbasi; Meral Akdogan; Yeliz Sokmen; Sedef Kuran; Ramazan Idilman
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 4.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

5.  Copper:caeruloplasmin ratio.

Authors:  Patrick J Twomey; Adie Viljoen; Ivan M House; Timothy M Reynolds; Anthony S Wierzbicki
Journal:  J Clin Pathol       Date:  2007-04       Impact factor: 3.411

6.  Atomic Absorption Spectrometry in Wilson's Disease and Its Comparison with Other Laboratory Tests and Paraclinical Findings.

Authors:  Fatemeh Mahjoub; Rana Fereiduni; Isa Jahanzad; Fatemeh Farahmand; Maryam Monajemzadeh; Mehri Najafi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

7.  A Case of Wilson's Disease in Patient with Mildly Elevated Liver Enzymes.

Authors:  Young-Hye Cho; Dong-Wook Jeong; Sang-Yeoup Lee; Son-Ki Park; Ki-Tae Yoon; Yun-Jin Kim; Jeong-Ku Lee; Yu-Hyun Lee
Journal:  Korean J Fam Med       Date:  2011-03-31

8.  High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study.

Authors:  Osman Virit; Salih Selek; Mahmut Bulut; Haluk Asuman Savas; Hakim Celik; Ozcan Erel; Hasan Herken
Journal:  Behav Brain Funct       Date:  2008-11-18       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.